British Columbia Investment Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-62,538
| Closed | -$1.77M | – | 700 |
|
|
2025
Q1 | $1.77M | Sell |
62,538
-16
| -0% | -$454 | 0.01% | 644 |
|
|
2024
Q4 | $2.6M | Buy |
62,554
+8,212
| +15% | +$341K | 0.02% | 584 |
|
|
2024
Q3 | $3.63M | Sell |
54,342
-7,985
| -13% | -$534K | 0.02% | 451 |
|
|
2024
Q2 | $7.4M | Buy |
62,327
+23,633
| +61% | +$2.81M | 0.04% | 298 |
|
|
2024
Q1 | $4.12M | Buy |
38,694
+1,454
| +4% | +$155K | 0.03% | 373 |
|
|
2023
Q4 | $3.7M | Buy |
37,240
+7,772
| +26% | +$773K | 0.03% | 376 |
|
|
2023
Q3 | $3.04M | Sell |
29,468
-99
| -0.3% | -$10.2K | 0.03% | 366 |
|
|
2023
Q2 | $3.59M | Buy |
29,567
+480
| +2% | +$58.3K | 0.03% | 335 |
|
|
2023
Q1 | $4.47M | Sell |
29,087
-366
| -1% | -$56.2K | 0.05% | 281 |
|
|
2022
Q4 | $5.29M | Sell |
29,453
-4,061
| -12% | -$729K | 0.06% | 246 |
|
|
2022
Q3 | $3.96M | Sell |
33,514
-6,219
| -16% | -$735K | 0.04% | 300 |
|
|
2022
Q2 | $5.68M | Sell |
39,733
-13,469
| -25% | -$1.92M | 0.05% | 272 |
|
|
2022
Q1 | $9.17M | Sell |
53,202
-7,168
| -12% | -$1.23M | 0.06% | 263 |
|
|
2021
Q4 | $15.3M | Sell |
60,370
-2,743
| -4% | -$697K | 0.09% | 204 |
|
|
2021
Q3 | $24.3M | Buy |
63,113
+4,453
| +8% | +$1.71M | 0.14% | 118 |
|
|
2021
Q2 | $13.8M | Buy |
58,660
+13,292
| +29% | +$3.12M | 0.08% | 220 |
|
|
2021
Q1 | $5.94M | Sell |
45,368
-1,380
| -3% | -$181K | 0.04% | 344 |
|
|
2020
Q4 | $4.88M | Sell |
46,748
-452
| -1% | -$47.2K | 0.03% | 392 |
|
|
2020
Q3 | $3.34M | Buy |
47,200
+3,584
| +8% | +$254K | 0.03% | 439 |
|
|
2020
Q2 | $2.8M | Buy |
+43,616
| New | +$2.8M | 0.03% | 447 |
|